Egalet (EGLT) Gains as FDA Challenge Still on Table

Egalet Corp (NASDAQ: EGLT) shares rose 6.9% to $5.18. Egalet disclosed that its challenge to the FDA for MorphaBond exclusivity is still being considered. Share volume was 765,000, compared to an all-day average of 661,000